(Q39482081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Expression and clinical relevance of MET and ALK in Ewing sarcomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

ChEBI release 2020-05-28

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

William Leenders

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

Yvonne M H Versleijen-Jonkers

22 February 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Melissa H S Roeffen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Uta E Flucke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Myrella Vlenterie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Hendrik W Schreuder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Winette T A van der Graaf

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Otto C Boerman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

25 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

427-436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group

22 February 2020

cites work

1 reference

Targets for cancer therapy in childhood sarcomas

21 January 2018

1 reference

c-Met: structure, functions and potential for therapeutic inhibition

21 January 2018

1 reference

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

MET overexpression turns human primary osteoblasts into osteosarcomas.

21 January 2018

1 reference

Anaplastic lymphoma kinase proteins in growth control and cancer

21 January 2018

1 reference

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms

21 January 2018

1 reference

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

21 January 2018

1 reference

Inhibition of ALK signaling for cancer therapy

21 January 2018

1 reference

Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.

21 January 2018

1 reference

Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines

21 January 2018

1 reference

Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases

21 January 2018

1 reference

Prognostic significance of c-Met expression in glioblastomas

21 January 2018

1 reference

Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future

21 January 2018

1 reference

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

21 January 2018

1 reference

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma

21 January 2018

1 reference

Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors.

21 January 2018

1 reference

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients

21 January 2018

1 reference

ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction.

21 January 2018

1 reference

Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program

21 January 2018

1 reference

Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program

21 January 2018

1 reference

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

21 January 2018

1 reference

The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma

21 January 2018

1 reference

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program.

21 January 2018

1 reference

Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor

21 January 2018

1 reference

Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study.

21 January 2018

1 reference

Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1.

21 January 2018

1 reference

Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data

21 January 2018

1 reference

VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer

21 January 2018

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib

21 January 2018

1 reference

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335077%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference